Abstract

Introduction and Background: Diabetes mellitus is a chronic endocrine disorder. Diabetic foot is most common complication observed in patients with diabetes mellitus which may leads to debilitating disability like gangrene, non healing sepsis and amputation. Clinically diabetic foot occurs due to diabetic neuropathy or ishchemic or combined neuro-ischemic. Aim and Objectives: This study was conducted with aim to evaluate the problem of diabetic foot among type 1 and type 2 diabetic mellitus patients and to increase the awareness regarding practice of proper preventive measures among them. Objectives were to find out prevalence of diabetic foot among type 1 and type 2 diabetes mellitus patients and to evaluate practice of proper preventive measures to prevent diabetic foot among them.

Materials And Methods: A cross sectional study conducted among diagnosed patients of type 1 and type 2 diabetes mellitus visiting at Dhiraj Hospital, SBKSMIRC, SVDU, Vadodara between January 2017 to April 2017. Total 98 patients were studied as per inclusion and exclusion criteria. Participants were examined clinically for neuropathy and ischemic features in both feet for diagnosis of diabetic foot, while questionnaire based interview done for evaluation of practice of preventive measures among them. Data was compiled and statistically analyzed. Observations and Results: Prevalence of diabetic foot was found 32.8% in male and 30% in female diabetic patients. Prevalence of diabetic foot was 86.4% in type 1 diabetes mellitus patients and 15.8% in type 2 diabetis mellitus patients. 58.6% of patients with diabetic foot were practicing good care and preventive measures while practice of preventive care was found irregular in 41.4% of patients with diabetic foot. Medico-legal examination for disability related to diabetic foot and neuropathy is to be done as per Government of India guidelines under the Rights of Persons with Disabilities Act and Rules.

Conslusion: Diabetic mellitus is a chronic incurable disorder till date. Common complications of diabetes mellitus like diabetic foot and diabetic foot ulcer needs proper preventive care and management. So that morbidity and disability can be prevented in patients with diabetes mellitus.

• 1.   Boulton AJM. The diabetic foot. Medicine. 2002;30(2):64–66.
• 2.   Singh N, Armstrong DG, Lipsky BA. Preventing Foot Ulcers in Patients With Diabetes. JAMA. 2005;293(2):217–228.
• 3.   Hinchliffe RJ, Brownrigg JRW, Apelqvist J, et al. IWGDF Guidance on the diagnosis, prognosis and management of peripheral artery disease in patients with foot ulcers in diabetes. Diabetes/Metabolism Research and Reviews. 2016;32(Suppl 1):37–44.
• 4.   Selva Olid A, Solà I, Barajas-Nava LA, et al. Systemic antibiotics for treating diabetic foot infections. Cochrane Database of Systematic Reviews. 2015;(9):CD009061.
• 5.   Yazdanpanah L, Nasiri M, Adarvishi S. Literature review on the management of diabetic foot ulcer. World Journal of Diabetes. 2015;6(1):37–53.
• 6.   Bus SA, Lavery LA, Monteiro-Soares M, et al. Guidelines on the prevention of foot ulcers in persons with diabetes (IWGDF 2019 update). Diabetes/Metabolism Research and Reviews. 2020;36(Suppl 1):e3269.
• 7.   Centers for Disease Control and Prevention (CDC). National Diabetes Statistics Report: Estimates of Diabetes and Its Burden in the United States, 2014. Atlanta (GA): U.S. Department of Health and Human Services; 2014. p. 6.
• 8.   Watkins PJ. The diabetic foot. BMJ. 2003;326(7396):977–979.
• 9.   World Health Organization (WHO). Global Report on Diabetes. Geneva: World Health Organization; 2016. p. 6–9.
• 10.   Whiting DR, Guariguata L, Weil C, Shaw J. IDF Diabetes Atlas: Global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Research and Clinical Practice. 2011;94(3):311–321.
• 11.   World Health Organization (WHO). Diabetes Country Profiles 2016 - India. Geneva: World Health Organization; 2016.
• 12.   Kumar S, Ashe HA, Parnell LN, et al. The Prevalence of Foot Ulceration and its Correlates in Type 2 Diabetic Patients: a Population-based Study. Diabetic Medicine. 1994;11(5):480–484.
• 13.   Daneman D. Type 1 diabetes. The Lancet. 2006;367(9513):847–858.
• 14.   Gadepalli R, Dhawan B, Sreenivas V, et al. A clinico-microbiological study of diabetic foot ulcers in an Indian tertiary care hospital. Diabetes Care. 2006;29(8):1727–1732.
• 15.   Viswanathan V, Jasmine JJ, Snehalatha C, Ramachandran A. Prevalence of pathogens in diabetic foot infection in South Indian type 2 diabetic patients. The Journal of the Association of Physicians of India. 2002;50:1013–1016.
• 16.   Sekhar MS, Thomas RR, Unnikrishnan MK, et al. Impact of diabetic foot ulcer on health-related quality of life: A cross-sectional study. Seminars in Vascular Surgery. 2015;28(3–4):165–171.
• 17.   All India Institute of Medical Sciences (AIIMS). Manual for Doctors to Evaluate Permanent Physical Impairment. New Delhi: AIIMS; 1982. p. 4–5.
• 18.   Department of Empowerment of Persons with Disabilities (Divyangjan). Guidelines for the purpose of assessing the extent of specified disability in a person included under the Rights of Persons with Disabilities Act, 2016. New Delhi: Ministry of Social Justice and Empowerment, Government of India; 2018.
• 19.   Department of Empowerment of Persons with Disabilities (Divyangjan). The Rights of Persons with Disabilities Rules, 2017. New Delhi: Ministry of Social Justice and Empowerment, Government of India; 2017.

Data Sharing Statement

Funding